SPRO: Spero Therapeutics, Inc. Stock

by  •  • Comments Off on SPRO: Spero Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 70.80
Enterprise Value ($M) 7.28
Book Value ($M) 80.50
Book Value / Share 1.49
Price / Book 0.88
NCAV ($M) -5.85
NCAV / Share -0.11
Price / NCAV -12.10

Profitability (mra)
Return on Invested Capital (ROIC) 0.20
Return on Assets (ROA) 0.16
Return on Equity (ROE) 0.33

Liquidity (mrq)
Quick Ratio 1.39
Current Ratio 1.39

Balance Sheet (mrq) ($M)
Current Assets 63.53
Assets 149.88
Liabilities 69.38
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
1 day ago 13G/A Anson Funds Management LP 6.90 -12.73

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-14 105,611 314,514 33.58
2024-11-13 34,243 323,598 10.58
2024-11-12 27,154 166,263 16.33
2024-11-11 30,197 186,850 16.16

(click for more detail)

Similar Companies
SLDB – Solid Biosciences Inc. SLRN – Acelyrin, Inc.
SNDX – Syndax Pharmaceuticals, Inc. SRPT – Sarepta Therapeutics, Inc.
SRRK – Scholar Rock Holding Corporation


Financial data and stock pages provided by
Fintel.io